Unequal global access to inflammatory bowel disease (IBD) therapies creates profound health inequities. The increasing prevalence of IBD in Western countries, driven by high incidence rates and low ...

Chrome’s new “Save to Google Drive” option is in the release version behind a flag and uploads files straight from the PDF ...

H. Lundbeck A/S (Lundbeck) today announced the acceptance of its new drug application (NDA) for Vyepti® (eptinezumab) by the Ministry of Health, Labor and Welfare (MHLW) in Japan.

The Guide aims to unlock transition capital for hard to abate sectors and accelerate decarbonisation through a clear, cross border framework.

A new study finds that while some parents are opposed to the use of AI-generated images in children’s stories, most are willing to accept these ...

Recently, an in-depth study addressing this question was jointly conducted by Associate Professor Ting Meng from the College ...

Broadening our portfolio with new projects and partnerships  Events during the third quarter 2025 New data on lecanemab were presented at the AAIC-congress focused on long-term efficacy and safety, ...

Gemini effectively transformed my chaotic Drive folder into something searchable without keywords. It also allows me to ...

Explore the idea of a single, secure digital identity for accessing all government services. Learn about the technical challenges, security, and user experience considerations.

Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) approved CAPLYTA® (lumateperone) as an adjunctive therapy with antidepressants for the treatment of major ...

New analysis compares literacy vs. poverty rates for 10,000 districts, 42,000 schools and 3 million kids. Is your school a ...